Paula Hammond
Vermögen: 208 254 $ am 30.06.2026
Vermögen: 208 254 $ am 30.06.2026
Paula Hammond was the founder of Layerbio, Inc., founded in 2013, where the title held was Director.
Current jobs include Independent Director at Alector, Inc. since 2020; Director at Advanced Chemotherapy Technologies, Inc.; Board of Director at FWH Management Co LLC since 2021; Director at Sail Biomedicines Inc; Professor & Head-Chemical Engineering at Massachusetts Institute of Technology; Member at American Academy of Arts & Sciences; Professor at David H.
Koch Institute for Integrative Cancer Research; Venture Partner at Catalio Capital Management LP; Founding Member at Institute For Soldier Nanotechnologies; Member at Koch Institute For Integrative Cancer Research; and Member at President's Council of Advisors on Science & Technology.
Former jobs include Director at Senda Biosciences, Inc., and roles on the Scientific Advisory Board at Svaya Nanotechnologies, Inc. and Moderna, Inc. Education includes undergraduate (1984) and doctorate (1993) degrees from Massachusetts Institute of Technology, and graduate education at Georgia Institute of Technology.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ALECTOR, INC. 0,09 % | 17.06.2026 | 103.609 ( 0,09 % ) | 208 254 $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ALECTOR, INC. | Direktor/Vorstandsmitglied | 20.03.2020 |
Sail Biomedicines
Sail Biomedicines Pharmaceuticals: MajorHealth Technology Engages in design and deployment of programmable medicines | Direktor/Vorstandsmitglied | - |
Koch Institute For Integrative Cancer Research | Corporate Officer/Principal | - |
The Engine Accelerator, Inc.
The Engine Accelerator, Inc. Investment ManagersFinance Engine Ventures seeks investment opportunities in companies located in the United States. The firm targets companies operating across a broad range of sectors and industries. It provides financing for early stage transactions. | Direktor/Vorstandsmitglied | 14.09.2021 |
Advanced Chemotherapy Technologies, Inc.
Advanced Chemotherapy Technologies, Inc. Medical SpecialtiesHealth Technology Develops a novel device for infusing chemotherapies directly into poorly-vascularized pancreatic tumors | Direktor/Vorstandsmitglied | - |
Catalio Capital Management LP
Catalio Capital Management LP Investment ManagersFinance Catalio Capital invests in public and private companies located in the United States. The firm targets companies operating in the fields of life sciences developing next-generation drugs, devices and diagnostics, data, tools and innovative healthcare sectors. It provides financing for seed, early and later stage capital requirements and also makes co-investments. | Private Equity Investor | - |
American Academy of Arts & Sciences
American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services Operates as organization which honours excellence and convenes leaders | Corporate Officer/Principal | - |
Institute For Soldier Nanotechnologies | Corporate Officer/Principal | - |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Corporate Officer/Principal | - |
| ░░░░░ ░░ ░░░░ ░░░░░░░░░ ░░░ ░░░░░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| Unternehmen | Position | Ende |
|---|---|---|
| ░░░░░░░░░ ░░░░ | ░░░░░░░░ | - |
| ░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░ ░░░░ | ░░░░░░░ | - |
| ░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░ | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 16 |
|---|---|
Svaya Nanotechnologies, Inc.
Svaya Nanotechnologies, Inc. Industrial SpecialtiesProcess Industries Develops and manufactures multifunction polyfilms | Process Industries |
Layerbio, Inc.
Layerbio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which provides drug delivery technologies in ophthalmology | Commercial Services |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Georgia Institute of Technology
Georgia Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Academy of Arts & Sciences
American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services Operates as organization which honours excellence and convenes leaders | Commercial Services |
President's Council of Advisors on Science & Technology
President's Council of Advisors on Science & Technology General GovernmentGovernment Provides the Administration services to science and technology | Government |
Alector, Inc.
Alector, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for Alzheimer’s disease and other neurodegenerative disorders | Health Technology |
David H. Koch Institute for Integrative Cancer Research
David H. Koch Institute for Integrative Cancer Research Miscellaneous Commercial ServicesCommercial Services Operates as cancer research center | Commercial Services |
Advanced Chemotherapy Technologies, Inc.
Advanced Chemotherapy Technologies, Inc. Medical SpecialtiesHealth Technology Develops a novel device for infusing chemotherapies directly into poorly-vascularized pancreatic tumors | Health Technology |
The Engine Accelerator, Inc.
The Engine Accelerator, Inc. Investment ManagersFinance Engine Ventures seeks investment opportunities in companies located in the United States. The firm targets companies operating across a broad range of sectors and industries. It provides financing for early stage transactions. | Finance |
Moderna, Inc.
Moderna, Inc. BiotechnologyHealth Technology Researches, develops, manufactures and commercializes mRNA-based respiratory & other virus vaccines, oncology and rare disease therapeutics | Health Technology |
Senda Biosciences, Inc.
Senda Biosciences, Inc. BiotechnologyHealth Technology Develops therapeutics to treat diseases | Health Technology |
Catalio Capital Management LP
Catalio Capital Management LP Investment ManagersFinance Catalio Capital invests in public and private companies located in the United States. The firm targets companies operating in the fields of life sciences developing next-generation drugs, devices and diagnostics, data, tools and innovative healthcare sectors. It provides financing for seed, early and later stage capital requirements and also makes co-investments. | Finance |
Institute For Soldier Nanotechnologies | |
Koch Institute For Integrative Cancer Research | |
Sail Biomedicines
Sail Biomedicines Pharmaceuticals: MajorHealth Technology Engages in design and deployment of programmable medicines | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen